Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-kappaB activation. [electronic resource]
Producer: 20080122Description: 1808-1818 p. digitalISSN:- 1529-4242
- Animals
- Blood Vessels -- ultrastructure
- Boronic Acids -- pharmacology
- Bortezomib
- Drug Evaluation, Preclinical
- Intercellular Adhesion Molecule-1 -- biosynthesis
- Intracellular Signaling Peptides and Proteins
- Laser-Doppler Flowmetry
- Male
- Mice
- Microscopy, Video
- Muscle, Skeletal -- blood supply
- NF-kappa B p50 Subunit -- antagonists & inhibitors
- Nitric Oxide Synthase Type II -- biosynthesis
- Protease Inhibitors -- pharmacology
- Proteasome Inhibitors
- Proteins -- genetics
- Pyrazines -- pharmacology
- Random Allocation
- Reperfusion Injury -- drug therapy
- Surgical Flaps -- blood supply
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.